S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers

Axon Enterprise (AXON) Stock Price, News & Analysis

$293.60
-3.98 (-1.34%)
(As of 04/19/2024 ET)
Today's Range
$291.35
$299.53
50-Day Range
$263.73
$324.09
52-Week Range
$175.37
$329.87
Volume
551,405 shs
Average Volume
404,298 shs
Market Capitalization
$22.16 billion
P/E Ratio
127.65
Dividend Yield
N/A
Price Target
$312.64

Axon Enterprise MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.90 Rating Score
Upside/​Downside
6.5% Upside
$312.64 Price Target
Short Interest
Healthy
3.02% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.13mentions of Axon Enterprise in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
34.43%
From $2.44 to $3.28 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.80 out of 5 stars

Industrial Products Sector

99th out of 159 stocks

Ordnance & Accessories, Except Vehicles & Guided Missiles Industry

2nd out of 5 stocks

AXON stock logo

About Axon Enterprise Stock (NASDAQ:AXON)

Axon Enterprise, Inc. is a leading provider of law enforcement technology solutions that enable using less-lethal weapons, body cameras, and cloud-based software. The company's mission is to protect life by providing innovative solutions that increase transparency and accountability in law enforcement. Axon's products and services include body-worn cameras, digital evidence management software, less-lethal weapons, and crime scene investigation tools.

Axon's primary target market is law enforcement agencies in the United States and abroad. The company's key customers include police departments, sheriff's offices, and federal law enforcement agencies. Axon is headquartered in Scottsdale, Arizona, with additional offices in Seattle, Washington, and London, UK. The company was founded in 1993 as TASER International Inc. and rebranded as Axon in 2017. Axon has also been recognized for its corporate social responsibility efforts, including its commitment to reducing the environmental impact of its products and operations.

Axon's management team is led by Chief Executive Officer and founder Patrick (Rick) Smith, who has been with the company since its inception. Before founding Axon, Smith worked as a software engineer at Honeywell and Intel. He has a bachelor's degree in electrical engineering from Harvard University and a master's from Stanford University.

Axon has experienced strong revenue growth over the past few years, driven by law enforcement agencies' adoption of body cameras and digital evidence management software. The company has been reporting increasing revenue each year for the past several years, and in 2022 it reached a milestone reaching meaningful profitability numbers for the first time. Axon's profit margins have also improved over the past few years, with the company reporting a gross margin averaging around 60%. Axon has a relatively low debt and more than enough assets to cover the company's debts. 

Axon's valuation metrics are relatively high compared to its industry peers, reflecting its strong growth prospects and leadership position in the law enforcement technology market. Axon's price-to-earnings ratio and price-to-book ratio are much higher than industry peers. Axon's stock price has experienced significant volatility over the past few years, driven by various factors, including regulatory changes, news events, and earnings reports. 

Axon Enterprise operates in the law enforcement technology industry, providing products and services to improve public safety. The company primarily focuses on producing and selling conducted electrical weapons (CEWs), body-worn cameras, and software solutions designed to streamline the law enforcement process.

The market for law enforcement technology is highly competitive, with major players such as Motorola Solutions, Inc. and Digital Ally Inc. competing for market share. The industry is also highly regulated, with stringent quality control and safety standards in place. Any missteps or quality issues could damage the company's reputation and lead to regulatory action.

One of Axon's key advantages in the market is its strong brand recognition and reputation for quality. The company's body-worn cameras are considered the best in the industry, and its software solutions are highly regarded. In addition, the company has built a loyal customer base over the years, with a significant percentage of its revenue coming from repeat business.

The law enforcement technology industry is facing significant headwinds. The ongoing debate around police reform and the use of force by law enforcement officers has led to increased scrutiny of companies like Axon, and there is a risk that sales could decline as a result. In addition, the industry is facing pressure from lower-cost competitors, and there is a risk that Axon's pricing strategy could become less effective in the face of increasing competition.

AXON Stock Price History

AXON Stock News Headlines

Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Axon Enterprise (NASDAQ:AXON) Price Target Raised to $400.00
AXON May 2024 290.000 call
AXON Jan 2026 390.000 call
AXON May 2024 450.000 call
See More Headlines
Receive AXON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Axon Enterprise and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
4/20/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Ordnance & accessories, except vehicles & guided missiles
Sub-Industry
Systems Software
Current Symbol
NASDAQ:AXON
Employees
4,260
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$312.64
High Stock Price Target
$400.00
Low Stock Price Target
$233.00
Potential Upside/Downside
+6.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.90
Research Coverage
10 Analysts

Profitability

Net Income
$174.23 million
Pretax Margin
9.91%

Debt

Sales & Book Value

Annual Sales
$1.56 billion
Cash Flow
$3.07 per share
Book Value
$21.51 per share

Miscellaneous

Free Float
70,860,000
Market Cap
$22.16 billion
Optionable
Optionable
Beta
0.93
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Should I Buy Axon Enterprise Stock? AXON Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Axon Enterprise, Inc.:

  • Axon Enterprise's share price recently hit a new 52-week high, indicating positive momentum and potential for further growth.
  • Analysts have raised price targets on Axon Enterprise, suggesting confidence in the company's future performance.
  • Institutional investors have been actively buying shares of Axon Enterprise, signaling strong interest from experienced market participants.
  • Average rating of "Moderate Buy" and a consensus price target of $312.64 indicate positive sentiment and potential upside for investors.
  • Axon Enterprise has a market cap of $24.46 billion, reflecting the company's size and stability in the market.

Cons

Investors should be bearish about investing in Axon Enterprise, Inc. for these reasons:

  • A downgrade from a "buy" rating to a "hold" rating by StockNews.com may raise concerns about the company's future performance.
  • Recent insider transactions, such as President Joshua Isner selling shares, could indicate lack of confidence from within the company.
  • The company's stock price has experienced fluctuations, with a recent decrease of 0.1%, suggesting potential volatility in the short term.
  • Debt-to-equity ratio of 0.42 may raise concerns about the company's financial leverage and risk exposure.
  • Axon Enterprise's price-to-earnings ratio of 140.91 may indicate that the stock is currently overvalued compared to industry peers.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, April 11, 2024. Please send any questions or comments about these Axon Enterprise pros and cons to contact@marketbeat.com.

AXON Stock Analysis - Frequently Asked Questions

Should I buy or sell Axon Enterprise stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axon Enterprise in the last twelve months. There are currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AXON shares.
View AXON analyst ratings
or view top-rated stocks.

What is Axon Enterprise's stock price target for 2024?

10 Wall Street research analysts have issued 12 month target prices for Axon Enterprise's stock. Their AXON share price targets range from $233.00 to $400.00. On average, they predict the company's share price to reach $312.64 in the next year. This suggests a possible upside of 6.5% from the stock's current price.
View analysts price targets for AXON
or view top-rated stocks among Wall Street analysts.

How have AXON shares performed in 2024?

Axon Enterprise's stock was trading at $258.33 at the beginning of 2024. Since then, AXON shares have increased by 13.7% and is now trading at $293.6050.
View the best growth stocks for 2024 here
.

Are investors shorting Axon Enterprise?

Axon Enterprise saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 2,280,000 shares, a drop of 7.3% from the March 15th total of 2,460,000 shares. Based on an average trading volume of 461,500 shares, the short-interest ratio is currently 4.9 days.
View Axon Enterprise's Short Interest
.

When is Axon Enterprise's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our AXON earnings forecast
.

How were Axon Enterprise's earnings last quarter?

Axon Enterprise, Inc. (NASDAQ:AXON) posted its quarterly earnings data on Tuesday, February, 27th. The biotechnology company reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.29. The biotechnology company had revenue of $432.14 million for the quarter, compared to analysts' expectations of $418.97 million. Axon Enterprise had a net margin of 11.14% and a trailing twelve-month return on equity of 14.11%.

What guidance has Axon Enterprise issued on next quarter's earnings?

Axon Enterprise issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.9 billion-$1.9 billion, compared to the consensus revenue estimate of $1.9 billion.

What other stocks do shareholders of Axon Enterprise own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axon Enterprise investors own include Novavax (NVAX), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Micron Technology (MU), TherapeuticsMD (TXMD), ACADIA Pharmaceuticals (ACAD), bluebird bio (BLUE) and Arena Pharmaceuticals (ARNA).

When did Axon Enterprise IPO?

Axon Enterprise (AXON) raised $251 million in an IPO on Thursday, June 11th 2015. The company issued 17,900,000 shares at a price of $13.00-$15.00 per share. Jefferies, Evercore ISI and RBC Capital Markets served as the underwriters for the IPO and JMP Securities and Baird were co-managers.

Who are Axon Enterprise's major shareholders?

Axon Enterprise's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (0.43%), Sumitomo Mitsui Trust Holdings Inc. (0.23%), Vaughan Nelson Investment Management L.P. (0.14%), Los Angeles Capital Management LLC (0.13%), Artemis Investment Management LLP (0.12%) and AMF Tjanstepension AB (0.05%). Insiders that own company stock include Adriane M Brown, Brittany Bagley, Caitlin Elizabeth Kalinowski, Hadi Partovi, Jawad A Ahsan, Jeffrey C Kunins, Joshua Isner, Julie A Cullivan, Luke Larson, Mark W Kroll, Matthew R Mcbrady, Michael Garnreiter and Patrick W Smith.
View institutional ownership trends
.

How do I buy shares of Axon Enterprise?

Shares of AXON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AXON) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners